RISHI GUPTA

Profile

First Name

: RISHI

Middle Name

:

Last Name

: GUPTA

Related Companies
Titles
Company Name
Related People
DIRECTOR
GELESIS INC
MENDY AXELRAD, ELON BOMS, ERIC ELENKO, MEGHAN FITZGERALD, ROBERT FORRESTER, JOHN LAMATTINA, ELLIOT MALTZ, YISHAI ZOHAR
DIRECTOR
SIENTRA, INC.
ROBERT ADELMAN, MICHELE PARK, MATTHEW PIGEON, NICK SIMON, JOEL SMITH, HANI ZEINI
DIRECTOR
AVITIDE, INC.
ERRIK ANDERSON, PHILIP FERNEAU, TILLMAN GERNGROSS, COLIN GREENSPON, KEVIN ISETT, KEVIN ISSETT, SCOTT KENNEDY, WARREN KETT, CLAUDIO NESSI, IAN RATCLIFFE, MICHAEL ROSS, AJAY ROYAN, JON SHELLER, JONATHAN SHELLER
DIRECTOR
SYMBIOMIX THERAPEUTICS, LLC
JOSEPH AMPREY, BEN AUSPITZ, THOMAS BECK, KAREN DAWES, ROBERT JACKS, KLAUS VEITINGER
DIRECTOR
DIMENSION THERAPEUTICS, INC.
BENJAMIN AUSPITZ, THOMAS BECK, ALLAN FOX, JAY K. HACHIGIAN, DONALD HAYDEN, DONALD J. HAYDEN, DONALD J. HAYDEN, JR., ANNALISA JENKINS
DIRECTOR
MEVES PHARMACEUTICALS, INC.
BEN AUSPITZ, PETER BARBER, JOSHUA GRASS
DIRECTOR
ATTENUA, INC.
DINA CHAYA MOGHRABI, MICHAEL KITT, JING LIANG, HUGH RIENHOFF, KURT VON EMSTER
DIRECTOR
TURNSTONE BIOLOGICS CORP.
BRAD BOLZON, MICHAEL BURGESS, MAURA CAMPBELL, JEREL DAVIS, SAMMY FARAH, ROBERT GOULD, JANE HENDERSON, STEFAN LARSON, PATRICK MACHADO, JOSE MANUEL OTERO
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GOLDEN TEAK CAPITAL L.P.
DIRECTOR
NEUROPACE INC
ISABELLA ABATI, JAMES BLAIR, VINCE BURGESS, MIKE FAVET, DAVID FISCHELL, FRANK FISCHER, GREG GARFIELD, NAEL KASSAR, REBECCA KUHN, JOSEPH LACOB, RAY LARKIN, MARTHA MORRELL, CHUCK NEWHALL, EVAN NORTON, BENJAMIN PLESS, RENEE RYAN, JONATHAN SILVERSTEIN, DEBRA SMOLLEY, BRAD VALE
DIRECTOR
VERONA PHARMA PLC
KEN CUNNINGHAM, DAVID EBSWORTH, MARTIN EDWARDS, MARK W. HAHN, PATRICK HUMPHREY, JAN-ANDERS KARLSSON, KENNETH NEWMAN, CLAIRE POLL, KATHLEEN RICKARD, MAHENDRA SHAH, ANDREW SINCLAIR, VIKAS SINHA, PETER SPARGO, ANDERS ULLMAN, DAVID ZACCARDELLI
DIRECTOR
CHARM THERAPEUTICS INC.
LAKSHYADITYA SINGH AITHANI, KIM BLACKWELL, GARY GLICK, MAHESH KUDARI, MUZAMMIL MANSURI, MATTHEW MCAVINEY, BRIGGS MORRISON, NIHAL SINHA
DIRECTOR
DELFI DIAGNOSTICS, INC.
PETER BACH, PETER B. BACH, JENNIFER BUECHEL, NICHOLAS DRACOPOLI, MICHAEL DYBBS, ELIZABETH HOMANS, JUSTIN KAO, DOUGLAS SCHENKEL, AMOOLYA SINGH, LEE-ANN SMITH-FREEMAN, WILLIAM STEVENS, WILLIAM J. STEVENS, SUSAN TOUSI, JACOB VAN NAARDEN, VICTOR VELCULESCU, GREG YAP
DIRECTOR
AER THERAPEUTICS, INC.
JOHN FAHY, THOMAS MATHERS, CHRISTY SHAFFER, JAMES SHAFFER, TIM SHANNON
DIRECTOR
HELICORE BIOVENTURES I, INC.
PATRICK R CRUTCHER, JING LIANG, BRIAN LIU, HUGH YOUNG RIENHOFF, JR., CARL RIZZUTO
DIRECTOR
ENLIVEN THERAPEUTICS, INC.
CHRISTOPH M. ADAMS, METTE KIRSTINE AGGER, RAHUL BALLAL, JAKE BAUER, DAVID BONITA, MARK CHIN, HELEN COLLINS, BARBARA DALTON, MIKA DERYNCK, CARL GOLDFISCHER, RICHARD HEYMAN, BENJAMIN HOHL, ROBERT HOPFNER, SAMUEL KINTZ, JOSEPH P. LYSSIKATOS, JAMES G. MCARTHUR, DAVID MOTT, SARA NAYEEM, ANISH PATEL, ANDREW PHILLIPS
DIRECTOR
WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
STEVEN GEOVANIS, . WILSHIRE ADVISORS LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-08
D
Link
HEDGE FUND 
 
 
 
2026-04-01 
2025-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-12-01 
2025-12-16
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2025-09-03
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-19 
2025-02-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-01-24 
2025-01-03
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2024-04-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-21 
2024-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-10 
2024-01-10
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2023-04-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-06 
2023-02-15
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2022-12-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-09 
2022-07-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-10 
2022-06-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-18 
2021-12-08
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2021-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-29 
2020-12-11
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2020-08-31
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-19 
2020-07-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-22 
2019-11-08
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2019-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-15 
2019-09-04
D
Link
HEDGE FUND 
 
 
Equity 
2019-08-27 
2019-01-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-04 
2018-08-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-09 
2018-04-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-04-17 
2018-03-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-15 
2018-01-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-18 
2017-06-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-13 
2016-05-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-22 
2015-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-23 
2015-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-20 
2014-07-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-03 
2014-07-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-03 
2014-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-27 
2012-06-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-28 
2011-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-25 
2011-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-30